<DOC>
	<DOCNO>NCT00158470</DOCNO>
	<brief_summary>Access care treatment use antiretroviral drug expand Vietnam next year . The ANRS 1210 study pilot program evaluate feasibility simplify antiretroviral treatment use three antiretroviral drug day . The objective assess efficacy tolerance treatment well understand difficulty link social behavioural condition patient different stage treatment .</brief_summary>
	<brief_title>Feasibility Study Once Daily Antiretroviral Regimen Vietnam ( ANRS 1210 VIETAR )</brief_title>
	<detailed_description>Despite high number infect subject ( estimate 250,000 end 2004 ) rapid spread HIV infection Vietnam , use anti-retroviral therapy remain limited . However , access care treatment expand Vietnam next year support national international organisation . ANRS 1210 study first pilot program use highly active antiretroviral therapy ( HAART ) evaluate efficacy tolerance antiretroviral therapy deliver adult external system medical care , Ho Chi Minh City . This feasibility study also objective evaluate cause treatment failure assess social behavioural condition patient different stage treatment . The present study open trial direct individual benefit . The chosen treatment once-daily administration 3TC , ddI Efavirenz deliver HIV infect adult CD4 count 200/mm3 . The duration study eighteen month main evaluation six month . One hundred patient select outpatient consultation Binh Trieu hospital Tropical Diseases Hospital Ho Chi Minh City . The main criterion evaluation immunological response 6 month , opportunistic infection event proportion patient undergo regular monitor 6 month . Viral response also appreciate , technical question , main criterion study . Patients also administer questionnaire trained independent interviewer adherence treatment , mental well-being , housing nutrition , drug sexual behaviour , social support disclosure order study association sociobehavioural dimension , adherence viral load two successive follow-up visit .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Man woman 18 year old HIV infect Written inform consent sign CD4 count low 200/mm3 No previous antiretroviral treatment Weight 45 kilo and/or body mass index 16 Karnofsky Index equal 70 percent Pregnant woman woman without effective contraception Opportunistic infection compromise realisation treatment Tumoral pathology Progressive psychiatric affection Previous history peripheral neuropathy pancreatitis Hemoglobin 90 g/l PMN neutrophil 1.0G/l Platelets 50G/l Liver enzymes 5 time normal value Lipase and/or amylase 2 time normal value Prothrombin rate 50 percent Plasmatic creatinine 200 micromoles/l</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>HIV infection</keyword>
	<keyword>inject drug user</keyword>
	<keyword>HAART</keyword>
	<keyword>daily regimen</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>